Annotation Detail for COMT
Basic Information Top
Gene Symbol: | COMT ( - ) |
---|---|
Gene Full Name: | catechol-O-methyltransferase |
Band: | 22q11.21 |
Quick Links | Entrez ID:1312; OMIM: 116790; Uniprot ID:COMT_HUMAN; ENSEMBL ID: ENSG00000093010; HGNC ID: 2228 |
Relate to Another Database: | SFARIGene; denovo-db |
Pathway ID | Pathway Name |
---|---|
PWY-6342 | noradrenaline and adrenaline degradation |
PWY-6334 | L-dopa degradation |
PWY6666-2 | dopamine degradation |
Pathway ID | Pathway Name |
---|---|
hsa00140 | Steroid hormone biosynthesis |
hsa00350 | Tyrosine metabolism |
hsa01100 | Metabolic pathways |
Pathway ID | Pathway Name |
---|---|
Synaptic Transmission | |
Biological oxidations |
No data |
Pathway ID | Pathway Name |
---|---|
P00001 | Adrenaline and noradrenaline biosynthesis |
Pathway ID | Pathway Name |
---|---|
500215 | Methylation |
500157 | Enzymatic degradation of Dopamine by monoamine oxidase |
500156 | Enzymatic degradation of dopamine by COMT |
500155 | Dopamine clearance from the synaptic cleft |
No data |
No data |
Desease Name |
---|
obsessive compulsive disorder |
ovarian cancer |
bipolar disorder |
neuroticism |
cognitive function |
Parkinson's disease |
AGING |
menarche |
CARDIOVASCULAR |
Osteoarthritis, Hip |
CHEMDEPENDENCY |
performance on the Wisconsin Card Sorting Test |
menopause |
hormone disturbance |
skeletal muscle properties |
schizotypal traits |
aggressive personality traits |
Arthralgia |
CANCER |
PSYCH |
Weight Gain |
Depression, Postpartum |
PHARMACOGENOMIC |
alcoholism |
breast cancer |
hypertension |
bipolar affective disorder. |
suicide |
anorexia nervosa |
adenomyosis endometriosis |
personality disorders |
NEUROLOGICAL |
eating disorders |
smoking cessation |
psychiatric manifestations of velo-cardio-facial syndrome |
schizophrenia |
prostate carcinoma |
METABOLIC |
obesity |
information processing |
REPRODUCTION |
psychoses |
major depressive disorder |
panic disorder |
obsessive compusive diorder |
sex hormone binding globulin |
estradiol |
oxidative stress |
heroin abuse |
No data |
Desease Name |
---|
Schizophrenia, susceptibility to |
Panic disorder, susceptibility to |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C433466 | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone results in decreased activity of COMT protein | decreases activity | 20334432 |
C433466 | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone binds to COMT protein | affects binding | 12584150 |
C433466 | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone results in decreased activity of COMT protein | decreases activity | 12584150 |
C433466 | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | COMT protein results in increased methylation of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | increases methylation | 12584150 |
C048152 | 1-carboxysalsolinol | COMT protein results in increased methylation of 1-carboxysalsolinol | increases methylation | 11160877 |
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of COMT mRNA | increases expression | 19933214 |
C053499 | 2,3-dihydroxynaphthalene | COMT protein results in increased methylation of 2,3-dihydroxynaphthalene | increases methylation | 11160877 |
C053499 | 2,3-dihydroxynaphthalene | COMT protein results in increased methylation of 2,3-dihydroxynaphthalene | increases methylation | 11160877 |
C475868 | 2-hydroxy-3-methoxyestradiol | COMT protein affects the chemical synthesis of 2-hydroxy-3-methoxyestradiol | affects chemical synthesis | 15377160 |
C001390 | 2-hydroxyestradiol | COMT protein affects the metabolism of 2-hydroxyestradiol | affects metabolic processing | 15377160 |
C001390 | 2-hydroxyestradiol | COMT protein results in increased methylation of 2-hydroxyestradiol | increases methylation | 11160877 |
C001390 | 2-hydroxyestradiol | COMT protein results in increased methylation of 2-hydroxyestradiol | increases methylation | 11160877 |
C001390 | 2-hydroxyestradiol | COMT protein results in increased metabolism of and results in decreased activity of 2-hydroxyestradiol | decreases activity|increases metabolic processing | 18497090 |
C022830 | 2-methoxyestradiol | COMT protein affects the chemical synthesis of 2-methoxyestradiol | affects chemical synthesis | 15377160 |
C022830 | 2-methoxyestradiol | COMT protein results in increased chemical synthesis of 2-methoxyestradiol | increases chemical synthesis | 15292328 |
C423629 | 3,4,5,6-tetrachlorocatechol | COMT protein results in increased methylation of 3,4,5,6-tetrachlorocatechol | increases methylation | 11160877 |
C032940 | 3,4-dihydroxyacetophenone | COMT protein results in increased methylation of 3,4-dihydroxyacetophenone | increases methylation | 11160877 |
C000989 | 3,4-dihydroxymandelic acid | COMT protein results in increased methylation of 3,4-dihydroxymandelic acid | increases methylation | 11160877 |
C066344 | 3-methoxycatechol | COMT protein results in increased methylation of 3-methoxycatechol | increases methylation | 11160877 |
C420684 | 3-O-methyl-DOPA | [entacapone results in decreased activity of COMT protein] which results in decreased abundance of 3-O-methyl-DOPA | decreases abundance|decreases activity | 12898346 |
C420684 | 3-O-methyl-DOPA | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of 3-O-methyl-DOPA | decreases abundance|decreases activity | 10047930 7566641 11248589 12898346 |
C420684 | 3-O-methyl-DOPA | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3-O-methyl-DOPA | decreases activity|increases abundance | 11432539 |
C025525 | 3-O-methylgallic acid | COMT protein results in increased methylation of 3-O-methylgallic acid | increases methylation | 11160877 |
C035207 | 4-amino-2,6-dinitrotoluene | 4-amino-2,6-dinitrotoluene affects the expression of COMT mRNA | affects expression | 21346803 |
C038861 | 4-chlorocatechol | COMT protein results in increased methylation of 4-chlorocatechol | increases methylation | 11160877 |
C038861 | 4-chlorocatechol | COMT protein results in increased methylation of 4-chlorocatechol | increases methylation | 11160877 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of COMT mRNA | decreases expression | 12419474 |
C014036 | 4-hydroxyestradiol-17 beta | COMT protein affects the metabolism of 4-hydroxyestradiol-17 beta | affects metabolic processing | 15377160 |
C014036 | 4-hydroxyestradiol-17 beta | COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta | increases methylation | 18192686 |
C014036 | 4-hydroxyestradiol-17 beta | daidzein inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
C014036 | 4-hydroxyestradiol-17 beta | Estradiol inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
C014036 | 4-hydroxyestradiol-17 beta | Genistein inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
C014036 | 4-hydroxyestradiol-17 beta | COMT protein results in increased metabolism of and results in decreased activity of 4-hydroxyestradiol-17 beta | decreases activity|increases metabolic processing | 18497090 |
C013074 | 4-isopropylcatechol | COMT protein results in increased methylation of 4-isopropylcatechol | increases methylation | 11160877 |
C013074 | 4-isopropylcatechol | COMT protein results in increased methylation of 4-isopropylcatechol | increases methylation | 11160877 |
C018599 | 4-methylcatechol | COMT protein results in increased methylation of 4-methylcatechol | increases methylation | 11160877 |
C018599 | 4-methylcatechol | COMT protein results in increased methylation of 4-methylcatechol | increases methylation | 11160877 |
C001833 | 4-nitrocatechol | COMT protein results in increased methylation of 4-nitrocatechol | increases methylation | 11160877 |
C001833 | 4-nitrocatechol | COMT protein results in increased methylation of 4-nitrocatechol | increases methylation | 11160877 |
C027802 | 5-hydroxydopamine | COMT protein results in increased methylation of 5-hydroxydopamine | increases methylation | 11160877 |
D000082 | Acetaminophen | Acetaminophen affects the expression of COMT mRNA | affects expression | 17562736 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of COMT mRNA | decreases expression | 17202762 18246545 |
D000255 | Adenosine Triphosphate | [Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased activity of COMT protein] which results in decreased abundance of Adenosine Triphosphate | decreases abundance|decreases activity | 14975680 |
D000255 | Adenosine Triphosphate | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Adenosine Triphosphate | decreases abundance|decreases activity | 14975680 |
D012435 | S-Adenosylhomocysteine | S-Adenosylhomocysteine results in decreased activity of COMT protein | decreases activity | 10064789 |
D012436 | S-Adenosylmethionine | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of S-Adenosylmethionine] | decreases activity|decreases reaction|increases abundance | 16758261 |
D006710 | Homocysteine | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of Homocysteine] | decreases activity|decreases reaction|increases abundance | 16758261 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of COMT mRNA | affects expression | 16483693 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased expression of COMT mRNA | increases expression | 12420312 |
D003913 | Dextroamphetamine | COMT gene SNP affects the susceptibility to Dextroamphetamine | affects response to substance | 12716966 |
D000661 | Amphetamine | Amphetamine results in increased expression of COMT mRNA | increases expression | 16916582 |
D000661 | Amphetamine | COMT protein affects the reaction [Amphetamine results in increased abundance of Dopamine] | affects reaction|increases abundance | 14574438 |
D001545 | Benserazide | COMT protein results in increased methylation of Benserazide | increases methylation | 11160877 |
D001545 | Benserazide | COMT protein results in increased methylation of Benserazide | increases methylation | 11160877 |
C095105 | bexarotene | bexarotene results in decreased expression of COMT mRNA | decreases expression | 16648578 |
C095105 | bexarotene | bexarotene results in increased expression of COMT mRNA | increases expression | 16648578 |
C466310 | BIA 3-335 | BIA 3-335 results in decreased activity of COMT protein | decreases activity | 15566291 |
C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of COMT mRNA | increases expression | 15912405 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of COMT mRNA | decreases expression | 12419474 |
C040048 | caffeic acid | COMT protein results in increased methylation of caffeic acid | increases methylation | 11160877 |
D002230 | Carbidopa | COMT protein results in increased methylation of Carbidopa | increases methylation | 11160877 |
D002230 | Carbidopa | COMT protein results in increased methylation of Carbidopa | increases methylation | 11160877 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of COMT mRNA | decreases expression | 16239168 |
D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased activity of COMT protein | decreases activity | 14975680 |
D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | [Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased activity of COMT protein] which results in decreased abundance of Adenosine Triphosphate | decreases abundance|decreases activity | 14975680 |
C034221 | catechol | COMT protein results in increased methylation of catechol | increases methylation | 11160877 |
C034221 | catechol | COMT protein results in increased methylation of catechol | increases methylation | 11160877 |
D002395 | Catecholamines | Catecholamines inhibits the reaction [COMT protein results in increased methylation of Estradiol] | decreases reaction|increases methylation | 15292328 |
D002395 | Catecholamines | COMT protein affects the metabolism of Catecholamines | affects metabolic processing | 15292328 |
C023386 | chlorinated dibenzofurans | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 15858227 |
C023386 | chlorinated dibenzofurans | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 15858227 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of COMT mRNA | increases expression | 18812211 |
D003000 | Clonidine | Clonidine results in increased expression of COMT mRNA | increases expression | 12423672 |
D003024 | Clozapine | COMT gene polymorphism results in increased susceptibility to Clozapine | increases response to substance | 17123785 |
D003024 | Clozapine | COMT protein affects the susceptibility to Clozapine | affects response to substance | 17123785 |
D003024 | Clozapine | [tolcapone results in decreased activity of COMT protein] promotes the reaction [Clozapine results in increased abundance of Dopamine] | decreases activity|increases abundance|increases reaction | 15190105 |
C004742 | daidzein | daidzein inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
C004742 | daidzein | daidzein results in decreased activity of COMT protein | decreases activity | 18497090 18192686 |
C004742 | daidzein | daidzein results in decreased expression of COMT mRNA | decreases expression | 18497090 18192686 |
C004742 | daidzein | fulvestrant inhibits the reaction [daidzein results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18497090 18192686 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of COMT mRNA | increases expression | 16962226 |
D003976 | Diazinon | Diazinon results in decreased expression of COMT mRNA | decreases expression | 18812211 |
D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 15784690 |
D004026 | Dieldrin | Dieldrin results in increased expression of COMT mRNA | increases expression | 18812211 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of COMT mRNA | decreases expression | 18042831 |
D004041 | Dietary Fats | [Tetrachlorodibenzodioxin co-treated with Dietary Fats] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 20435547 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 18544905 |
C061532 | dihydrexidine | COMT protein results in increased methylation of dihydrexidine | increases methylation | 11160877 |
C061532 | dihydrexidine | COMT protein results in increased methylation of dihydrexidine | increases methylation | 11160877 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | COMT protein results in increased methylation of 3,4-Dihydroxyphenylacetic Acid | increases methylation | 11160877 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 11793163 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | COMT protein results in increased methylation of 3,4-Dihydroxyphenylacetic Acid | increases methylation | 11160877 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 15190105 16012872 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | [tolcapone results in decreased activity of COMT protein] promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid] | decreases abundance|decreases activity|increases reaction | 12957500 |
D015102 | 3,4-Dihydroxyphenylacetic Acid | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 12957500 |
C010117 | dihydroxyphenylethylene glycol | COMT protein results in increased methylation of dihydroxyphenylethylene glycol | increases methylation | 11160877 |
D004280 | Dobutamine | COMT protein results in increased methylation of Dobutamine | increases methylation | 11160877 |
D004280 | Dobutamine | Dobutamine results in increased expression of COMT mRNA | increases expression | 12423672 |
D007980 | Levodopa | COMT protein results in increased methylation of Levodopa | increases methylation | 11160877 |
D007980 | Levodopa | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of Homocysteine] | decreases activity|decreases reaction|increases abundance | 16758261 |
D007980 | Levodopa | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of S-Adenosylmethionine] | decreases activity|decreases reaction|increases abundance | 16758261 |
D007980 | Levodopa | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Levodopa | decreases activity|increases abundance | 11432539 9333106 10047930 10872643 10809409 12898346 |
D007980 | Levodopa | COMT protein results in increased methylation of Levodopa | increases methylation | 11160877 |
D007980 | Levodopa | Levodopa binds to COMT protein | affects binding | 12584150 |
D004298 | Dopamine | COMT protein results in increased methylation of Dopamine | increases methylation | 11160877 |
D004298 | Dopamine | [entacapone results in decreased activity of COMT protein] which results in increased abundance of Dopamine | decreases activity|increases abundance | 12898346 |
D004298 | Dopamine | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Dopamine | decreases activity|increases abundance | 7566641 12898346 11248589 |
D004298 | Dopamine | COMT protein affects the reaction [Amphetamine results in increased abundance of Dopamine] | affects reaction|increases abundance | 14574438 |
D004298 | Dopamine | COMT protein results in increased methylation of Dopamine | increases methylation | 11160877 |
D004298 | Dopamine | [tolcapone results in decreased activity of COMT protein] promotes the reaction [Clozapine results in increased abundance of Dopamine] | decreases activity|increases abundance|increases reaction | 15190105 |
D004391 | Dust | Dust results in decreased expression of COMT mRNA | decreases expression | 17805423 |
C071192 | entacapone | [entacapone results in decreased activity of COMT protein] which results in decreased abundance of 3-O-methyl-DOPA | decreases abundance|decreases activity | 12898346 |
C071192 | entacapone | [entacapone results in decreased activity of COMT protein] which results in increased abundance of Dopamine | decreases activity|increases abundance | 12898346 |
C071192 | entacapone | entacapone results in decreased activity of COMT protein | decreases activity | 15566291 20334432 |
C071192 | entacapone | entacapone binds to COMT protein | affects binding | 19783845 |
C071192 | entacapone | entacapone results in decreased activity of COMT protein | decreases activity | 20334432 19783845 |
C071192 | entacapone | entacapone results in decreased activity of COMT protein | decreases activity | 19198095 |
D004837 | Epinephrine | COMT protein results in increased methylation of Epinephrine | increases methylation | 11160877 |
D004837 | Epinephrine | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Epinephrine | decreases activity|increases abundance | 11248589 |
D004837 | Epinephrine | COMT protein results in increased methylation of Epinephrine | increases methylation | 10064789 |
D004837 | Epinephrine | [COMT protein results in increased methylation of Epinephrine] which results in increased abundance of Metanephrine | increases abundance|increases methylation | 8821542 10064789 |
D004837 | Epinephrine | tolcapone inhibits the reaction [[COMT protein results in increased methylation of Epinephrine] which results in increased abundance of Metanephrine] | decreases reaction|increases abundance|increases methylation | 8821542 |
C007628 | esculetin | COMT protein results in increased methylation of esculetin | increases methylation | 11160877 |
D004958 | Estradiol | COMT protein polymorphism results in decreased abundance of Estradiol analog | decreases abundance | 15288375 |
D004958 | Estradiol | Estradiol inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
D004958 | Estradiol | Estradiol results in decreased activity of COMT protein | decreases activity | 18192686 18497090 |
D004958 | Estradiol | Estradiol results in decreased expression of COMT mRNA | decreases expression | 18497090 |
D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18497090 18192686 |
D004958 | Estradiol | Catecholamines inhibits the reaction [COMT protein results in increased methylation of Estradiol] | decreases reaction|increases methylation | 15292328 |
D004958 | Estradiol | COMT protein results in increased metabolism of and results in decreased activity of Estradiol | decreases activity|increases metabolic processing | 18566989 |
D004958 | Estradiol | COMT protein results in increased methylation of Estradiol | increases methylation | 15292328 |
D004967 | Estrogens | COMT gene polymorphism affects the metabolism of Estrogens | affects metabolic processing | 15777990 |
D004967 | Estrogens | COMT protein affects the metabolism of Estrogens | affects metabolic processing | 15987428 |
D004967 | Estrogens | Estrogens results in decreased expression of COMT protein | decreases expression | 17138778 |
D002393 | Estrogens, Catechol | COMT protein polymorphism results in decreased metabolism of Estrogens, Catechol | decreases metabolic processing | 15288375 |
D002393 | Estrogens, Catechol | COMT protein results in increased methylation of and results in decreased activity of Estrogens, Catechol | decreases activity|increases methylation | 15455371 |
D002393 | Estrogens, Catechol | COMT protein results in increased metabolism of and results in decreased activity of Estrogens, Catechol | decreases activity|increases metabolic processing | 18566989 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 17942748 |
C017875 | fisetin | [fisetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | affects cotreatment|decreases activity | 16037419 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [daidzein results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18497090 18192686 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18192686 18497090 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Genistein results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18192686 18497090 |
D019833 | Genistein | fulvestrant inhibits the reaction [Genistein results in decreased expression of COMT mRNA] | decreases expression|decreases reaction | 18192686 18497090 |
D019833 | Genistein | Genistein inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol-17 beta] | decreases reaction|increases methylation | 18192686 |
D019833 | Genistein | Genistein results in decreased activity of COMT protein | decreases activity | 18192686 18497090 |
D019833 | Genistein | Genistein results in decreased expression of COMT mRNA | decreases expression | 18497090 18192686 |
D006719 | Homovanillic Acid | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid | decreases abundance|decreases activity | 11793163 |
D006719 | Homovanillic Acid | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid | decreases abundance|decreases activity | 16012872 15190105 |
C029424 | hydrazine | hydrazine results in decreased expression of COMT protein | decreases expression | 15370871 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of COMT mRNA | decreases expression | 12419474 |
D016627 | Oxidopamine | COMT protein results in increased methylation of Oxidopamine | increases methylation | 11160877 |
D007545 | Isoproterenol | COMT protein results in increased methylation of Isoproterenol | increases methylation | 11160877 |
C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 18544905 |
C067713 | lactacystin | lactacystin inhibits the reaction [TNF protein results in increased expression of COMT protein] | decreases reaction|increases expression | 17138778 |
C035420 | levodopa methyl ester | COMT protein results in increased methylation of levodopa methyl ester | increases methylation | 11160877 |
C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased activity of COMT protein | increases activity | 17573159 |
C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of COMT protein | increases expression | 17573159 |
D019290 | Megestrol Acetate | Megestrol Acetate results in increased expression of COMT protein | increases expression | 16939895 |
D008676 | Metanephrine | [COMT protein results in increased methylation of Epinephrine] which results in increased abundance of Metanephrine | increases abundance|increases methylation | 8821542 10064789 |
D008676 | Metanephrine | tolcapone inhibits the reaction [[COMT protein results in increased methylation of Epinephrine] which results in increased abundance of Metanephrine] | decreases reaction|increases abundance|increases methylation | 8821542 |
D008694 | Methamphetamine | COMT gene polymorphism affects the susceptibility to Methamphetamine | affects response to substance | 19462300 |
D008727 | Methotrexate | Methotrexate results in increased expression of COMT mRNA | increases expression | 15120968 |
D008750 | Methyldopa | COMT protein results in increased methylation of Methyldopa | increases methylation | 11160877 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | [tolcapone results in decreased activity of COMT protein] promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid] | decreases abundance|decreases activity|increases reaction | 12957500 |
C040015 | myricetin | [myricetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | affects cotreatment|decreases activity | 16037419 |
D009532 | Nickel | Nickel results in decreased expression of COMT mRNA | decreases expression | 18812211 |
C506350 | nitrocatechol | COMT protein results in increased methylation of nitrocatechol analog | increases methylation | 11160877 |
D009638 | Norepinephrine | COMT protein results in increased methylation of Norepinephrine | increases methylation | 11160877 |
D009638 | Norepinephrine | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Norepinephrine | decreases activity|increases abundance | 11248589 |
C076029 | olanzapine | olanzapine results in increased expression of COMT mRNA | increases expression | 15964593 |
C057726 | OR486 | OR486 binds to COMT protein | affects binding | 12584150 |
C057726 | OR486 | OR486 results in decreased activity of COMT protein | decreases activity | 12584150 10064789 |
C057726 | OR486 | OR486 results in decreased activity of COMT protein | decreases activity | 15507517 15292328 |
C041786 | palm oil | palm oil results in decreased expression of COMT mRNA | decreases expression | 18042831 |
D010269 | Paraquat | Paraquat results in increased expression of COMT mRNA | increases expression | 17935786 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of COMT mRNA | decreases expression | 16510358 |
D016226 | Phosphorus, Dietary | Phosphorus, Dietary affects the expression of COMT mRNA | affects expression | 17651324 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COMT mRNA | affects binding|increases activity|increases expression | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of COMT mRNA | decreases expression | 18445702 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of COMT mRNA | decreases expression | 16940010 |
D028321 | Plant Preparations | COMT gene polymorphism affects the susceptibility to Plant Preparations | affects response to substance | 17602170 |
D011078 | Polychlorinated Biphenyls | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 15858227 |
D011078 | Polychlorinated Biphenyls | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 15858227 |
C008954 | polychlorodibenzo-4-dioxin | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 15858227 |
C008954 | polychlorodibenzo-4-dioxin | [Polychlorinated Biphenyls co-treated with polychlorodibenzo-4-dioxin co-treated with chlorinated dibenzofurans] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 15858227 |
D011374 | Progesterone | Progesterone results in decreased expression of COMT protein | decreases expression | 17138778 |
C009091 | protocatechuic acid | COMT protein results in increased methylation of protocatechuic acid | increases methylation | 11160877 |
C009091 | protocatechuic acid | COMT protein results in increased methylation of protocatechuic acid | increases methylation | 11160877 |
D011748 | Pyrogallol | COMT protein results in increased methylation of Pyrogallol | increases methylation | 11160877 |
D011794 | Quercetin | [Quercetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | affects cotreatment|decreases activity | 16037419 |
D011794 | Quercetin | Quercetin results in decreased activity of COMT protein | decreases activity | 15507517 |
D018967 | Risperidone | Risperidone results in increased expression of COMT mRNA | increases expression | 15964593 |
D013629 | Tamoxifen | COMT protein affects the metabolism of Tamoxifen | affects metabolic processing | 15288375 |
C038096 | tert-butylcatechol | COMT protein results in increased methylation of tert-butylcatechol | increases methylation | 11160877 |
C038096 | tert-butylcatechol | COMT protein results in increased methylation of tert-butylcatechol | increases methylation | 11160877 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of COMT mRNA | affects binding|increases expression | 16214954 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Dietary Fats] results in decreased expression of COMT mRNA | affects cotreatment|decreases expression | 20435547 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of COMT mRNA | increases expression | 19933214 18796159 |
D015647 | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | COMT protein results in increased methylation of 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | increases methylation | 11160877 |
C066340 | tolcapone | tolcapone results in decreased activity of COMT protein | decreases activity | 11793426 16758261 7768073 11248589 11432539 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of Homocysteine] | decreases activity|decreases reaction|increases abundance | 16758261 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of S-Adenosylmethionine] | decreases activity|decreases reaction|increases abundance | 16758261 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of 3-O-methyl-DOPA | decreases abundance|decreases activity | 10047930 11248589 7566641 12898346 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Adenosine Triphosphate | decreases abundance|decreases activity | 14975680 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid | decreases abundance|decreases activity | 11793163 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 11793163 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3-O-methyl-DOPA | decreases activity|increases abundance | 11432539 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Dopamine | decreases activity|increases abundance | 7566641 11248589 12898346 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Epinephrine | decreases activity|increases abundance | 11248589 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Levodopa | decreases activity|increases abundance | 11432539 9333106 10809409 12898346 10047930 10872643 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of Norepinephrine | decreases activity|increases abundance | 11248589 |
C066340 | tolcapone | tolcapone results in decreased activity of COMT protein | decreases activity | 15566291 20334432 |
C066340 | tolcapone | COMT protein results in increased methylation of tolcapone | increases methylation | 12584150 |
C066340 | tolcapone | tolcapone binds to COMT protein | affects binding | 19783845 |
C066340 | tolcapone | tolcapone inhibits the reaction [[COMT protein results in increased methylation of Epinephrine] which results in increased abundance of Metanephrine] | decreases reaction|increases abundance|increases methylation | 8821542 |
C066340 | tolcapone | tolcapone results in decreased activity of COMT protein | decreases activity | 20334432 19783845 15190105 16012872 10064789 2089102 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] promotes the reaction [Clozapine results in increased abundance of Dopamine] | decreases activity|increases abundance|increases reaction | 15190105 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid | decreases abundance|decreases activity | 15190105 16012872 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 15190105 16012872 |
C066340 | tolcapone | tolcapone results in decreased activity of COMT protein | decreases activity | 12957500 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid] | decreases abundance|decreases activity|increases reaction | 12957500 |
C066340 | tolcapone | [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | decreases activity|increases abundance | 12957500 |
C066340 | tolcapone | tolcapone results in decreased activity of COMT protein | decreases activity | 10651109 1977408 |
D014334 | Tropolone | Tropolone results in decreased activity of COMT protein | decreases activity | 10064789 |
C025643 | vinclozolin | vinclozolin affects the expression of COMT mRNA | affects expression | 19015723 |
D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in increased expression of COMT mRNA | affects cotreatment|increases expression | 15784690 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.62 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | 4-amino-2,6-dinitrotoluene | 13.02 | 7525203 | |
MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 13.02 | 12039119 | |
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 13.02 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 13.02 | 15322242 11752688 14514962 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 2.65 | 18287403 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.01 | 17505938 | |
MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.93 | 9612607 | |
MESH:D055371 | Acute Lung Injury | Nickel | 6.43 | 16166738 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 6.43 | 18653653 | |
MESH:D000230 | Adenocarcinoma | daidzein | 7.28 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 7.28 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 7.28 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Genistein | 7.28 | 11473722 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 2.26 | 6695378 10737359 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 17.45 | 19061943 19052882 16434500 18056438 17162532 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 17.45 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 17.45 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 17.45 | 16835633 | |
MESH:D000303 | Adrenal Cortex Diseases | Catecholamines | 6.39 | 6895166 | |
MESH:D000380 | Agranulocytosis | Clozapine | 4.16 | 14617031 12649775 16160616 | |
MESH:D000382 | Agricultural Workers' Diseases | Chlorpyrifos | 9.36 | 11874814 16611668 17119214 | |
MESH:D000382 | Agricultural Workers' Diseases | Diazinon | 9.36 | 16487989 | |
MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 9.36 | 11874814 | |
MESH:D017109 | Akathisia, Drug-Induced | tolcapone | 5.36 | 11080934 | |
MESH:D000544 | Alzheimer Disease | entacapone | 4.17 | 20150427 | |
MESH:D000544 | Alzheimer Disease | tolcapone | 4.17 | 20150427 | |
MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 5.14 | 16459022 16916582 18475255 15010207 | |
MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 3.46 | 10965797 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.14 | 11748828 | |
MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.41 | 17084956 | |
MESH:D000799 | Angioedema | Acetaminophen | 2.91 | 10982225 | |
MESH:D000855 | Anorexia | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 8.17 | 12183048 | |
MESH:D000855 | Anorexia | Amphetamine | 8.17 | 16101753 16084549 12183048 12005258 | |
MESH:D001008 | Anxiety Disorders | vinclozolin | 2.88 | 19015723 | |
MESH:D001161 | Arteriosclerosis | Dietary Fats | 6.95 | 15238619 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 6.95 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 5.23 | 17659584 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 5.23 | 15885639 | |
MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 2.81 | 17286800 | |
MESH:D020817 | Asperger Syndrome | Risperidone | 4.69 | 16401163 | |
MESH:D001260 | Ataxia Telangiectasia | Quercetin | 4.06 | 15336622 | |
MESH:D001284 | Atrophy | fulvestrant | 3.97 | 11514358 | |
MESH:D001289 | Attention Deficit Disorder with Hyperactivity | marker/mechanism | 10490706 | ||
MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Oxidopamine | 6.80 | 14699433 | |
MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Risperidone | 6.80 | 18349709 | |
MESH:D001321 | Autistic Disorder | marker/mechanism | 16917939 | ||
MESH:D001321 | Autistic Disorder | Acetaminophen | 4.41 | 18445737 | |
MESH:D001321 | Autistic Disorder | Homocysteine | 4.41 | 16297937 20468076 | |
MESH:D001321 | Autistic Disorder | Norepinephrine | 4.41 | 8570775 | |
MESH:D001321 | Autistic Disorder | olanzapine | 4.41 | 17069543 18685284 | |
MESH:D001321 | Autistic Disorder | Risperidone | 4.41 | 18026891 15492353 15994720 19368416 16239862 16379507 19013209 19232924 16948927 17929164 19154706 17069546 16730335 15930063 16601648 17019624 18349709 18775368 15543515 18278980 18080171 | |
MESH:D001321 | Autistic Disorder | S-Adenosylhomocysteine | 4.41 | 16917939 20468076 | |
MESH:D001321 | Autistic Disorder | S-Adenosylmethionine | 4.41 | 16917939 19056591 | |
MESH:D001327 | Autoimmune Diseases | Quercetin | 3.52 | 19761891 | |
MESH:D001714 | Bipolar Disorder | Risperidone | 3.96 | 18278980 19154706 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 6.01 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 6.01 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.86 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.10 | 15746008 | |
MESH:D001919 | Bradycardia | Isoproterenol | 4.28 | 6740701 | |
MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.40 | 17868700 | |
MESH:D001930 | Brain Injuries | Progesterone | 3.37 | 15845082 15380490 15665606 | |
MESH:D001943 | Breast Neoplasms | marker/mechanism | 9407957 15455371 16077979 | ||
MESH:D001943 | Breast Neoplasms | 2-hydroxyestradiol | 15.38 | 16675129 | |
MESH:D001943 | Breast Neoplasms | 2-methoxyestradiol | 15.38 | 15219808 18223236 | |
MESH:D001943 | Breast Neoplasms | 4-hydroxyestradiol-17 beta | 15.38 | 16675129 | |
MESH:D001943 | Breast Neoplasms | bexarotene | 15.38 | 16818667 16344269 | |
MESH:D001943 | Breast Neoplasms | Dieldrin | 15.38 | 15770527 11859874 | |
MESH:D001943 | Breast Neoplasms | Dietary Fats | 15.38 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 15.38 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 15.38 | 14630087 12948864 19861407 16675129 18497071 17018787 17261762 17289903 | |
MESH:D001943 | Breast Neoplasms | Estrogens, Catechol | 15.38 | 17261777 | |
MESH:D001943 | Breast Neoplasms | fulvestrant | 15.38 | 18984771 | |
MESH:D001943 | Breast Neoplasms | Genistein | 15.38 | 16541309 16873071 17200150 | |
MESH:D001943 | Breast Neoplasms | Methotrexate | 15.38 | 16978400 | |
MESH:D001943 | Breast Neoplasms | Nickel | 15.38 | 15986119 | |
MESH:D001943 | Breast Neoplasms | Plant Preparations | 15.38 | 17398067 | |
MESH:D001943 | Breast Neoplasms | Progesterone | 15.38 | 17614352 16175315 15562024 | |
MESH:D001943 | Breast Neoplasms | Quercetin | 15.38 | 18628248 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 15.38 | 19142967 15668708 19103187 19288272 18351453 17261762 18855134 19115204 16202921 11161223 19244106 15565566 18984771 19189210 17049068 19221464 17242785 19200415 18425577 18815881 16873071 20544844 19289846 20135344 19059307 19011961 21138602 19155303 19410462 19189212 20859285 17893378 20065188 19084267 16273361 18629630 18997820 21152245 18821012 20390343 16818667 19066611 17440819 20005174 19487384 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 15.38 | 20435547 | |
MESH:D002105 | Cadmium Poisoning | Quercetin | 4.61 | 16962696 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.55 | 16111702 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 2.89 | 3786805 16097048 10355542 16124888 15721981 16011737 15700767 16050911 15673190 16192424 16227642 18705752 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.05 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.61 | 19066611 | |
MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 15341023 | ||
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 14.75 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 14.75 | 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 14.75 | 18494052 19701751 16779866 16878318 19822196 18788625 16569478 19919837 18665156 18506893 20512989 16935385 19107877 17978847 20727157 19171122 16328049 17138121 10737359 17055752 18056438 20214788 20101231 17173139 16681979 16288022 16502159 20514400 20524982 10672840 19418558 17761372 19383236 18210153 20432363 18393292 21159647 19335982 16830150 19519916 11831363 19539802 16540662 17428255 18971187 3581430 17162532 3084413 20007298 16807293 19208518 20935162 18978308 19052882 18691550 18785209 16698587 20084675 19394651 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 14.75 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 14.75 | 15341023 | |
MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 14.75 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 14.75 | 20935162 20007298 6705139 1701930 17173139 | |
MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 14.75 | 12508355 19519916 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 14.75 | 16924424 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bexarotene | 2.82 | 16247446 | |
MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 4.06 | 17234771 | |
MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 3.31 | 17418620 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 2.80 | 17572228 | |
MESH:D006332 | Cardiomegaly | Isoproterenol | 11.48 | 11179087 7544033 | |
MESH:D006332 | Cardiomegaly | Norepinephrine | 11.48 | 11179087 | |
MESH:D006332 | Cardiomegaly | Quercetin | 11.48 | 19794523 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 11.48 | 16120746 18850075 18670907 | |
MESH:D002318 | Cardiovascular Diseases | daidzein | 11.76 | 16332659 | |
MESH:D002318 | Cardiovascular Diseases | Genistein | 11.76 | 16332659 | |
MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 11.76 | 16936243 | |
MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 11.76 | 16862667 | |
MESH:D016893 | Carotid Stenosis | Plant Preparations | 5.22 | 15158307 | |
MESH:D002375 | Catalepsy | Norepinephrine | 4.63 | 8216760 | |
MESH:D002386 | Cataract | 4-amino-2,6-dinitrotoluene | 8.95 | 14694615 | |
MESH:D002386 | Cataract | Acetaminophen | 8.95 | 10977129 | |
MESH:D002386 | Cataract | Adenosine Triphosphate | 8.95 | 15003327 | |
MESH:D002389 | Catatonia | olanzapine | 5.32 | 16772815 18071103 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4-hydroxyestradiol-17 beta | 7.49 | 18226522 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 7.49 | 2727394 7505956 21159647 17174075 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 7.49 | 18566989 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 3.36 | 4080065 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 6.67 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 6.67 | 16835633 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 5.33 | 17110522 17333356 15861022 16919318 11677210 16105132 17681005 | |
MESH:D002779 | Cholestasis | pirinixic acid | 5.33 | 19176532 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 1.63 | 16354765 8697196 12621046 15340226 15668235 | |
MESH:D003072 | Cognition Disorders | marker/mechanism | 17123785 | ||
MESH:D003072 | Cognition Disorders | Clozapine | 4.07 | 17123785 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 4.29 | 15824018 | |
MESH:D003110 | Colonic Neoplasms | Genistein | 4.29 | 17182828 | |
MESH:D003110 | Colonic Neoplasms | Quercetin | 4.29 | 15741050 17191121 19440933 16640504 11134977 19056647 17148506 | |
MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 2.61 | 15531428 | |
MESH:D015179 | Colorectal Neoplasms | Quercetin | 2.61 | 18095365 18852136 | |
MESH:D000013 | Congenital Abnormalities | 4-amino-2,6-dinitrotoluene | 6.54 | 15095906 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 6.54 | 17141729 14669216 | |
MESH:D003324 | Coronary Artery Disease | Homocysteine | 5.31 | 16379339 | |
MESH:D003324 | Coronary Artery Disease | Plant Preparations | 5.31 | 15158307 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 2.99 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 2.99 | 9562676 12039119 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.99 | 20055451 10048152 15322242 | |
MESH:D016638 | Critical Illness | Estrogens | 5.03 | 16670151 | |
MESH:D003456 | Cryptorchidism | vinclozolin | 3.46 | 14966744 | |
MESH:D003550 | Cystic Fibrosis | Methotrexate | 3.44 | 19747007 | |
MESH:D016757 | Death, Sudden, Cardiac | Risperidone | 4.69 | 20210726 | |
MESH:D003704 | Dementia | Polychlorinated Biphenyls | 7.82 | 16140633 | |
MESH:D003704 | Dementia | Risperidone | 7.82 | 11575062 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.46 | 19031437 | |
MESH:D003866 | Depressive Disorder | entacapone | 6.41 | 7768276 | |
MESH:D003866 | Depressive Disorder | tolcapone | 6.41 | 7768276 11224284 | |
MESH:D003865 | Depressive Disorder, Major | tolcapone | 4.10 | 10440460 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 4.64 | 12438553 | |
MESH:D017449 | Dermatitis, Allergic Contact | Nickel | 4.64 | 17100760 17244072 19470301 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.91 | 18249437 | |
MESH:D003877 | Dermatitis, Contact | Nickel | 3.79 | 2952479 | |
MESH:D003882 | Dermatomyositis | Methotrexate | 4.25 | 20191521 | |
MESH:D002658 | Developmental Disabilities | olanzapine | 4.01 | 17069543 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 2.97 | 19496084 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 9.90 | 16402076 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 9.90 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 9.90 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 9.90 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 9.90 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 6.20 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 6.20 | 19279558 | |
MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.60 | 17187935 | |
MESH:D003967 | Diarrhea | Dexamethasone | 2.86 | 7237001 | |
MESH:D004062 | DiGeorge Syndrome | marker/mechanism | |||
MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 11.36 | 15331141 | |
MESH:D006970 | Disorders of Excessive Somnolence | Risperidone | 11.36 | 16379507 | |
MESH:D053207 | Diurnal Enuresis | Risperidone | 5.74 | 17822346 | |
MESH:D004314 | Down Syndrome | Risperidone | 4.35 | 18349709 | |
MESH:D056486 | Drug-Induced Liver Injury | 4-amino-2,6-dinitrotoluene | 12.57 | 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 12.57 | 12594235 14550746 16109766 14986274 19164858 10915739 16081117 19739265 15968718 19416960 16485898 11461765 16177239 18071297 17562736 10663392 19085960 17906064 16393943 17522070 19370779 11529661 18713872 11834606 10774834 12705907 19923254 16227642 2444490 14725611 12540782 11287661 15619225 16781746 12153990 11421492 19420014 12958197 11739529 11743745 12392966 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 12.57 | 15968718 6884620 19085960 15998439 21278145 3786805 9327722 19336974 16227642 11566570 4309450 15027814 10915739 10092053 7120509 7179309 16177239 2869522 3732212 7440962 6623471 17522070 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 12.57 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | entacapone | 12.57 | 19783845 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 12.57 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | tolcapone | 12.57 | 19783845 16604736 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.17 | 19426721 | |
MESH:D004362 | Drug Toxicity | Lamivudine | 13.76 | 15040536 | |
MESH:D004362 | Drug Toxicity | Plant Preparations | 13.76 | 11033412 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 13.76 | 11462148 | |
MESH:D004362 | Drug Toxicity | Zidovudine | 13.76 | 15040536 | |
MESH:D004409 | Dyskinesia, Drug-Induced | Levodopa | 9.51 | 15893579 3690436 | |
MESH:D004409 | Dyskinesia, Drug-Induced | tolcapone | 9.51 | 11455177 | |
MESH:D050171 | Dyslipidemias | Clozapine | 6.48 | 16402076 | |
MESH:D050171 | Dyslipidemias | Dietary Fats | 6.48 | 18367378 | |
MESH:D004417 | Dyspnea | Diazinon | 3.88 | 16487989 | |
MESH:D004421 | Dystonia | Phenobarbital | 3.15 | 1851702 | |
MESH:D004485 | Eczema | Dexamethasone | 3.59 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 6.75 | 19703484 | |
MESH:D004487 | Edema | pirinixic acid | 6.75 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 6.75 | 12711302 11000095 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 2.97 | 18230668 15322242 16714409 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 10.31 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 10.31 | 17692515 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 10.31 | 19031437 | |
MESH:D004714 | Endometrial Hyperplasia | Genistein | 3.68 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | daidzein | 16.33 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 16.33 | 19148513 11473722 18566989 | |
MESH:D016889 | Endometrial Neoplasms | Estrogens, Catechol | 16.33 | 18566989 | |
MESH:D016889 | Endometrial Neoplasms | Genistein | 16.33 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 16.33 | 19155303 17893378 20544844 16202921 | |
MESH:D004715 | Endometriosis | Progesterone | 6.23 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 6.23 | 9294722 10568697 | |
MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 4.68 | 12954792 | |
MESH:D004751 | Enteritis | Clonidine | 5.20 | 8982514 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 3.22 | 3659116 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 2.95 | 3922381 11558140 | |
MESH:D004827 | Epilepsy | Epinephrine | 8.10 | 821787 | |
MESH:D004827 | Epilepsy | Norepinephrine | 8.10 | 821787 | |
MESH:D004827 | Epilepsy | Phenobarbital | 8.10 | 20417680 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.75 | 6401628 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 3.36 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 3.11 | 3659116 | |
MESH:D007172 | Erectile Dysfunction | daidzein | 4.15 | 14972507 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.18 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 3.30 | 16510608 | |
MESH:D017889 | Exfoliation Syndrome | Homocysteine | 4.79 | 16504073 | |
MESH:D054908 | Extensively Drug-Resistant Tuberculosis | entacapone | 11.62 | 19578428 | |
MESH:D054908 | Extensively Drug-Resistant Tuberculosis | tolcapone | 11.62 | 19578428 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.28 | 11564622 | |
MESH:D005221 | Fatigue | Amphetamine | 4.69 | 19890266 | |
MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 24.43 | 16239168 17595544 61145 15959796 19224547 12795759 12631006 16045604 | |
MESH:D005234 | Fatty Liver | Dietary Fats | 24.43 | 19551842 19004024 18296743 17967931 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 24.43 | 21071580 20387270 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 24.43 | 15345470 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 24.43 | 20131406 19236843 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 24.43 | 19224547 14986274 | |
MESH:D005234 | Fatty Liver | Zidovudine | 24.43 | 18299183 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.60 | 16709447 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.56 | 11858732 | |
MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 4.40 | 16997862 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.61 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 3.27 | 19069698 | |
MESH:D005355 | Fibrosis | Carbon Tetrachloride | 13.93 | 18705752 | |
MESH:D005355 | Fibrosis | Dietary Fats | 13.93 | 18296743 | |
MESH:D005355 | Fibrosis | Quercetin | 13.93 | 19474275 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 13.93 | 20067830 | |
MESH:D005756 | Gastritis | Acetaminophen | 2.75 | 16983495 | |
MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 4.02 | 16973722 | |
MESH:D005832 | Genital Diseases, Male | vinclozolin | 4.37 | 16417039 | |
MESH:D005901 | Glaucoma | Homocysteine | 4.43 | 16504073 | |
MESH:D005909 | Glioblastoma | Genistein | 8.29 | 16598420 | |
MESH:D005909 | Glioblastoma | myricetin | 8.29 | 19804834 | |
MESH:D005909 | Glioblastoma | Quercetin | 8.29 | 19804834 | |
MESH:D005910 | Glioma | Quercetin | 2.60 | 17643826 | |
MESH:D005911 | Gliosis | Paraquat | 4.23 | 11124998 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.66 | 10696789 | |
MESH:D006086 | Graft vs Host Disease | Methotrexate | 4.25 | 16518429 | |
MESH:D034381 | Hearing Loss | marker/mechanism | 19898482 | ||
MESH:D006330 | Heart Defects, Congenital | Homocysteine | 8.17 | 19638421 | |
MESH:D006330 | Heart Defects, Congenital | polychlorodibenzo-4-dioxin | 8.17 | 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 8.17 | 10048152 11294989 | |
MESH:D006333 | Heart Failure | Dobutamine | 8.37 | 17440445 | |
MESH:D006333 | Heart Failure | Isoproterenol | 8.37 | 18097624 | |
MESH:D006333 | Heart Failure | pirinixic acid | 8.37 | 20558911 | |
MESH:D006402 | Hematologic Diseases | Zidovudine | 3.86 | 12579204 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.50 | 11000095 | |
MESH:D006505 | Hepatitis | Carbon Tetrachloride | 6.73 | 19110552 19900420 | |
MESH:D006505 | Hepatitis | Diazinon | 6.73 | 16487989 | |
MESH:D006509 | Hepatitis B | Lamivudine | 4.26 | 17703166 | |
MESH:D019694 | Hepatitis B, Chronic | Lamivudine | 4.26 | 16476009 12044531 15631357 15309715 15274664 | |
MESH:D006521 | Hepatitis, Chronic | Methyldopa | 5.74 | 14986274 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 9.28 | 16109766 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 9.28 | 18467677 16221962 19176532 19772884 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 9.28 | 12621046 15340226 16120746 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.65 | 7520565 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.10 | 15709030 | |
MESH:D015658 | HIV Infections | Lamivudine | 7.70 | 11141242 20032539 9296927 17530837 | |
MESH:D015658 | HIV Infections | Nickel | 7.70 | 17263646 | |
MESH:D015658 | HIV Infections | Zidovudine | 7.70 | 11363243 11698656 17358032 20032539 11141242 | |
MESH:D019584 | Hot Flashes | Estradiol | 2.83 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.11 | 16959395 18606429 16354765 15340226 8697196 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 1.96 | 16870215 | |
MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.62 | 16899240 | |
MESH:D006937 | Hypercholesterolemia | Dietary Fats | 2.77 | 21332399 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 11.12 | 20558911 | |
MESH:D006943 | Hyperglycemia | Quercetin | 11.12 | 11834736 18262572 | |
MESH:D006943 | Hyperglycemia | Risperidone | 11.12 | 18278980 | |
MESH:D020138 | Hyperhomocysteinemia | Homocysteine | 7.63 | 17369066 18234410 17292331 | |
MESH:D020138 | Hyperhomocysteinemia | Levodopa | 7.63 | 16787708 16275827 | |
MESH:D006948 | Hyperkinesis | Amphetamine | 19.97 | 14960337 1977408 | |
MESH:D006948 | Hyperkinesis | Clozapine | 19.97 | 16046005 | |
MESH:D006948 | Hyperkinesis | dihydrexidine | 19.97 | 14960337 | |
MESH:D006948 | Hyperkinesis | Methamphetamine | 19.97 | 17658665 | |
MESH:D006949 | Hyperlipidemias | Dietary Fats | 2.77 | 21332399 | |
MESH:D006963 | Hyperphagia | olanzapine | 5.31 | 17933447 | |
MESH:D006973 | Hypertension | daidzein | 8.60 | 17169123 | |
MESH:D006973 | Hypertension | Dexamethasone | 8.60 | 17042910 | |
MESH:D006973 | Hypertension | Quercetin | 8.60 | 18356687 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 8.60 | 18850075 18670907 | |
MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 3.19 | 15338365 | |
MESH:D046110 | Hypertension, Pregnancy-Induced | Clonidine | 5.27 | 16612254 | |
MESH:D006984 | Hypertrophy | Isoproterenol | 4.36 | 12791704 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 2.91 | 16569931 16945680 | |
MESH:D007022 | Hypotension | Dopamine | 14.89 | 6740701 | |
MESH:D007022 | Hypotension | Epinephrine | 14.89 | 6740701 | |
MESH:D007022 | Hypotension | Isoproterenol | 14.89 | 6740701 | |
MESH:D007022 | Hypotension | Norepinephrine | 14.89 | 6740701 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 3.51 | 15869954 | |
MESH:D007247 | Infertility, Female | Dieldrin | 7.46 | 10630421 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 7.46 | 12013081 | |
MESH:D007248 | Infertility, Male | Diazinon | 13.99 | 12948887 16466525 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 13.99 | 17937319 | |
MESH:D007248 | Infertility, Male | fulvestrant | 13.99 | 11514358 | |
MESH:D007248 | Infertility, Male | Paraquat | 13.99 | 4850670 | |
MESH:D007248 | Infertility, Male | vinclozolin | 13.99 | 16467254 | |
MESH:D007249 | Inflammation | Dexamethasone | 15.47 | 8960868 11099482 | |
MESH:D007249 | Inflammation | Dietary Fats | 15.47 | 20412841 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 15.47 | 18785209 | |
MESH:D007249 | Inflammation | Nickel | 15.47 | 16166738 | |
MESH:D007249 | Inflammation | Progesterone | 15.47 | 15869954 | |
MESH:D007249 | Inflammation | Tamoxifen | 15.47 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 15.47 | 12878042 12200463 | |
MESH:D007251 | Influenza, Human | Quercetin | 3.58 | 16624496 | |
MESH:D007333 | Insulin Resistance | Dietary Fats | 8.41 | 18457598 11836018 | |
MESH:D007333 | Insulin Resistance | Estradiol | 8.41 | 16393666 16627594 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 8.41 | 16306350 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 2.50 | 16580747 | |
MESH:D007627 | Keloid | Quercetin | 4.06 | 17086741 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 6.53 | 15629191 12587719 | |
MESH:D007674 | Kidney Diseases | Estradiol | 6.53 | 15618244 | |
MESH:D007674 | Kidney Diseases | Quercetin | 6.53 | 16962696 | |
MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 3.44 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 8.08 | 15610895 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 8.08 | 18625569 | |
MESH:D007680 | Kidney Neoplasms | Zidovudine | 8.08 | 12579204 | |
MESH:D007805 | Language Development Disorders | Methotrexate | 4.24 | 9562676 | |
MESH:D007938 | Leukemia | Genistein | 4.70 | 18980019 17468513 | |
MESH:D007938 | Leukemia | Quercetin | 4.70 | 17468513 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 3.58 | 20370541 | |
MESH:D007984 | Leydig Cell Tumor | vinclozolin | 3.82 | 16417039 | |
MESH:D008064 | Lipidoses | Clozapine | 5.72 | 17567588 | |
MESH:D008064 | Lipidoses | Tamoxifen | 5.72 | 17567588 15342952 | |
MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 14.40 | 11408273 11903743 16239168 17334410 16943688 17174718 17157831 21278145 16221502 | |
MESH:D008103 | Liver Cirrhosis | Dietary Fats | 14.40 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 14.40 | 18665156 18407596 20032147 19638242 18522880 | |
MESH:D008103 | Liver Cirrhosis | Methotrexate | 14.40 | 14986274 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 14.40 | 21047994 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 13.57 | 18166357 16097048 14724832 13678700 17823541 16011737 14748882 17640975 16116963 16027843 15057751 14716833 18472332 18429990 14716496 12741479 15650968 12667390 11481614 12632512 15893842 17761835 18481824 15123356 18317297 15876570 17944888 18205269 18705752 12609069 20821823 10355542 16015684 17525996 12666154 12958196 17565644 18418968 18277467 17766677 15931870 15362042 12445418 17631135 12546737 17721639 18395914 15818738 16248980 18279442 18210741 18395095 17922224 18156304 17805973 16192424 14620537 17708605 15338365 15996030 18412020 12445421 16638106 17900296 16136751 15959796 17869086 18187930 18054572 17976157 18006644 15052691 17481882 16033810 18251166 12586293 15925388 18339082 12649538 18420326 12632514 18263696 12898905 17698563 17557913 18472094 15673190 17714472 18376398 12389079 15370692 14512876 15730626 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 13.57 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 13.57 | 14716833 14659978 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 13.57 | 17823541 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 13.57 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 13.57 | 17724770 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 13.57 | 12741479 | |
MESH:D008106 | Liver Cirrhosis, Experimental | S-Adenosylmethionine | 13.57 | 15983038 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 13.57 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 13.57 | 12878042 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 8.66 | 12969438 16610002 19014921 12587719 19460945 11587558 19784758 16611625 | |
MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 8.66 | 16246199 16964402 15720792 15830285 17285989 | |
MESH:D008107 | Liver Diseases | Chlorpyrifos | 8.66 | 15991261 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 8.66 | 17034775 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 8.66 | 19363144 | |
MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.27 | 15123358 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 6.70 | 16871587 17185352 | |
MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 6.70 | 16899240 14706259 | |
MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 17.69 | 19294768 | |
MESH:D008113 | Liver Neoplasms | Dieldrin | 17.69 | 9539021 8742319 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 17.69 | 9163691 19255062 18754104 2862719 21047994 21071580 18644402 16942905 19833225 2422723 19256749 19642983 19690152 20501860 20405173 15885732 20492335 18978307 10737359 21167192 19812893 19850985 19638242 18977376 19294768 19073162 19499222 20583210 21278145 19427195 12112319 19551842 19426721 20118626 20452335 20101389 12771043 15175105 20137499 20434301 19996281 19254457 19090486 18648771 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 17.69 | 19812893 19482888 15975961 8742319 19073162 21047994 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 17.69 | 20007298 15890375 16377806 | |
MESH:D008113 | Liver Neoplasms | Quercetin | 17.69 | 18980244 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 17.69 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 17.69 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 18.42 | 12014681 15583823 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 18.42 | 17942915 18544905 3124819 19539802 18093689 16267830 19004024 19009564 18164116 18775883 17854601 18079962 19519916 19126423 18282651 9362446 21159647 18308698 16842330 17174075 2563599 18253720 | |
MESH:D008114 | Liver Neoplasms, Experimental | kojic acid | 18.42 | 18544905 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 18.42 | 1399818 18308698 6150874 17172636 2563599 | |
MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 18.42 | 1423854 | |
MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 18.42 | 19519916 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 18.42 | 12151625 | |
MESH:D008133 | Long QT Syndrome | Dobutamine | 6.67 | 19353679 | |
MESH:D008133 | Long QT Syndrome | olanzapine | 6.67 | 20210726 | |
MESH:D008171 | Lung Diseases | Dobutamine | 3.87 | 16638327 | |
MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 4.09 | 18516814 | |
MESH:D008175 | Lung Neoplasms | bexarotene | 7.62 | 17849452 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 7.62 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 7.62 | 20512841 20970405 21163286 6695378 | |
MESH:D008175 | Lung Neoplasms | Quercetin | 7.62 | 16280456 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 7.62 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 7.62 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Zidovudine | 7.62 | 18800350 | |
MESH:D008223 | Lymphoma | Methotrexate | 3.26 | 17352296 | |
MESH:D016410 | Lymphoma, T-Cell, Cutaneous | bexarotene | 4.25 | 11161223 | |
MESH:D015674 | Mammary Neoplasms, Animal | marker/mechanism | 18424824 | ||
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 2.86 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | bexarotene | 11.89 | 19196722 19196723 15591091 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 11.89 | 17203775 11807958 11408345 16891317 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 11.89 | 14578162 12929590 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 11.89 | 17203775 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 11.89 | 19196722 14580682 16827153 11731420 19196723 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 9.56 | 19453300 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 9.56 | 19453300 | |
MESH:D008545 | Melanoma | Tamoxifen | 1.74 | 19393235 12393984 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 3.27 | 15990972 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 2.67 | 19513568 | |
MESH:D008591 | Meningomyelocele | Homocysteine | 4.64 | 16602021 | |
MESH:D001523 | Mental Disorders | Clozapine | 8.38 | 16856516 | |
MESH:D001523 | Mental Disorders | olanzapine | 8.38 | 16856516 | |
MESH:D001523 | Mental Disorders | Risperidone | 8.38 | 16856516 16596465 | |
MESH:D008607 | Mental Retardation | Risperidone | 3.70 | 18349709 | |
MESH:D008659 | Metabolic Diseases | olanzapine | 4.55 | 19142110 | |
MESH:D024821 | Metabolic Syndrome X | Clozapine | 7.59 | 19142101 | |
MESH:D024821 | Metabolic Syndrome X | Risperidone | 7.59 | 19142101 | |
MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.90 | 17358032 | |
MESH:D019964 | Mood Disorders | Risperidone | 4.93 | 17019624 | |
MESH:D009041 | Motion Sickness | Dextroamphetamine | 4.59 | 1613127 | |
MESH:D009062 | Mouth Neoplasms | Plant Preparations | 4.03 | 17418620 | |
MESH:D052016 | Mucositis | Methotrexate | 4.37 | 17488658 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 2.82 | 15867202 15744524 16118317 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 2.62 | 16239165 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 2.94 | 9809623 | |
MESH:D009203 | Myocardial Infarction | Genistein | 12.63 | 17141266 | |
MESH:D009203 | Myocardial Infarction | Homocysteine | 12.63 | 17412321 | |
MESH:D009203 | Myocardial Infarction | Isoproterenol | 12.63 | 15740881 19595682 19172585 16584858 16697266 16538859 17052832 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 12.63 | 19151258 | |
MESH:D009203 | Myocardial Infarction | Quercetin | 12.63 | 19595682 | |
MESH:D017202 | Myocardial Ischemia | Dobutamine | 6.85 | 12447174 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 6.85 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 18.80 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 18.80 | 17141266 | |
MESH:D015428 | Myocardial Reperfusion Injury | Norepinephrine | 18.80 | 15642760 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 18.80 | 16411023 | |
MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 18.80 | 19207477 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.56 | 17484760 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 4.13 | 9029167 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 4.13 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.12 | 19410462 | |
MESH:D009369 | Neoplasms | Dieldrin | 5.26 | 8820588 | |
MESH:D009369 | Neoplasms | pirinixic acid | 5.26 | 17405874 | |
MESH:D009369 | Neoplasms | Quercetin | 5.26 | 15185748 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | bexarotene | 7.86 | 19196722 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 7.86 | 19189210 19200415 19196722 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 2.83 | 17289903 | |
MESH:D009410 | Nerve Degeneration | Paraquat | 2.98 | 16893418 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 11.34 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Genistein | 11.34 | 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 11.34 | 14600291 | |
MESH:D019636 | Neurodegenerative Diseases | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 18.24 | 12349958 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 18.24 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 18.24 | 15183010 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 18.24 | 20387270 | |
MESH:D019636 | Neurodegenerative Diseases | Oxidopamine | 18.24 | 18514411 | |
MESH:D020078 | Neurogenic Inflammation | Quercetin | 3.51 | 17929310 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.18 | 20387270 | |
MESH:D020258 | Neurotoxicity Syndromes | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 6.69 | 16725203 | |
MESH:D020258 | Neurotoxicity Syndromes | Chlorpyrifos | 6.69 | 15081274 | |
MESH:D053206 | Nocturnal Enuresis | Risperidone | 5.40 | 17822346 | |
MESH:D009765 | Obesity | Clozapine | 7.81 | 19142110 18515891 | |
MESH:D009765 | Obesity | Dietary Fats | 7.81 | 19632207 16723640 18674790 20132043 21332399 18457598 17217161 11836018 20518802 | |
MESH:D009765 | Obesity | olanzapine | 7.81 | 18515891 | |
MESH:D009765 | Obesity | pirinixic acid | 7.81 | 20558911 | |
MESH:D009784 | Occupational Diseases | 4-amino-2,6-dinitrotoluene | 3.29 | 14694615 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 3.45 | 17016548 | |
MESH:D010024 | Osteoporosis | Genistein | 2.63 | 19401787 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 7.31 | 16169203 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 7.31 | 19495926 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 7.91 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Genistein | 7.91 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Progesterone | 7.91 | 16525653 17393432 | |
MESH:D010051 | Ovarian Neoplasms | Quercetin | 7.91 | 19005980 | |
MESH:D010146 | Pain | Acetaminophen | 1.68 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 6.04 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 6.04 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Quercetin | 6.04 | 16965848 | |
MESH:D010195 | Pancreatitis | Methyldopa | 5.01 | 10484002 | |
MESH:D016584 | Panic Disorder | marker/mechanism | |||
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.83 | 11578682 | |
MESH:D010212 | Papilloma | Hydrogen Peroxide | 3.21 | 12065085 | |
MESH:D010300 | Parkinson Disease | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 32.28 | 20334432 12584150 | |
MESH:D010300 | Parkinson Disease | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 32.28 | 15451049 16140633 11181820 | |
MESH:D010300 | Parkinson Disease | BIA 3-335 | 32.28 | 15566291 | |
MESH:D010300 | Parkinson Disease | Carbidopa | 32.28 | 7566641 | |
MESH:D010300 | Parkinson Disease | Dieldrin | 32.28 | 17291500 16809432 11181820 16112328 11445065 | |
MESH:D010300 | Parkinson Disease | entacapone | 32.28 | 11586115 17089403 20334432 19578428 19783845 | |
MESH:D010300 | Parkinson Disease | Homocysteine | 32.28 | 16275827 | |
MESH:D010300 | Parkinson Disease | Levodopa | 32.28 | 19594199 11432539 18328768 20334432 7566641 | |
MESH:D010300 | Parkinson Disease | Paraquat | 32.28 | 12911755 11181820 11445065 15824117 16140633 16510128 15451049 11124998 | |
MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 32.28 | 16702228 | |
MESH:D010300 | Parkinson Disease | tolcapone | 32.28 | 9754991 8635184 8739811 1977408 19783845 9591521 11586115 9305320 11746615 16758261 7566641 18328768 19578428 11793426 20334432 17089403 10651109 20216409 9333106 9708959 11432539 | |
MESH:D010302 | Parkinson Disease, Secondary | Oxidopamine | 8.43 | 15893579 11771942 | |
MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 8.43 | 16190885 | |
MESH:D020734 | Parkinsonian Disorders | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 15.37 | 12349958 | |
MESH:D020734 | Parkinsonian Disorders | entacapone | 15.37 | 18722529 | |
MESH:D020734 | Parkinsonian Disorders | Homovanillic Acid | 15.37 | 8817341 | |
MESH:D020734 | Parkinsonian Disorders | Levodopa | 15.37 | 11246459 18722529 8817341 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.32 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | 4-methylcatechol | 5.39 | 18219259 | |
MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 4.57 | 11550810 | |
MESH:D011014 | Pneumonia | Paraquat | 3.54 | 12504350 | |
MESH:D011041 | Poisoning | Diazinon | 3.52 | 17603234 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.68 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 10.78 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 10.78 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Quercetin | 10.78 | 19056647 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 2.95 | 21297632 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 6.48 | 11399792 11896295 11118676 11222880 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 6.48 | 18042343 18220299 19015723 | |
MESH:D011469 | Prostatic Diseases | vinclozolin | 4.02 | 18220299 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 3.05 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 17013881 | ||
MESH:D011471 | Prostatic Neoplasms | 2-methoxyestradiol | 2.08 | 16356831 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.08 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Estrogens, Catechol | 2.08 | 17261777 | |
MESH:D011471 | Prostatic Neoplasms | fisetin | 2.08 | 18922931 | |
MESH:D011471 | Prostatic Neoplasms | Genistein | 2.08 | 15256057 15378649 16925846 | |
MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 2.08 | 15721890 | |
MESH:D011471 | Prostatic Neoplasms | Quercetin | 2.08 | 14715546 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 2.08 | 15067354 | |
MESH:D011472 | Prostatitis | vinclozolin | 4.02 | 18629315 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.41 | 16919318 15861022 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 3.57 | 12752131 | |
MESH:D011565 | Psoriasis | Methotrexate | 3.02 | 17410198 | |
MESH:D011595 | Psychomotor Agitation | olanzapine | 4.69 | 18685284 | |
MESH:D011618 | Psychotic Disorders | Clozapine | 3.47 | 15331141 | |
MESH:D011654 | Pulmonary Edema | Isoproterenol | 4.33 | 10903255 | |
MESH:D011658 | Pulmonary Fibrosis | Paraquat | 2.48 | 17997886 16324872 | |
MESH:D051437 | Renal Insufficiency | Methotrexate | 3.82 | 17352296 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 1.85 | 19058328 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 6.45 | 18379247 11700416 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 6.45 | 11700416 | |
MESH:D012135 | Respiratory Sounds | Chlorpyrifos | 6.99 | 16611668 17119214 11874814 | |
MESH:D012135 | Respiratory Sounds | Paraquat | 6.99 | 11874814 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.96 | 18990726 | |
MESH:D012140 | Respiratory Tract Diseases | Chlorpyrifos | 3.97 | 16611668 17119214 | |
MESH:D012162 | Retinal Degeneration | Paraquat | 3.14 | 16458197 | |
MESH:D012206 | Rhabdomyolysis | Lamivudine | 4.62 | 9296927 | |
MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.43 | 18045962 | |
MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.61 | 16862918 | |
MESH:D012559 | Schizophrenia | marker/mechanism | 16234811 17123785 18583979 | ||
MESH:D012559 | Schizophrenia | Clozapine | 6.07 | 17726453 17667964 20107430 20168265 20521326 18806925 16141801 19369910 11763009 11151749 18855531 17123785 20580759 20521320 20452607 | |
MESH:D012559 | Schizophrenia | Homocysteine | 6.07 | 16641680 | |
MESH:D012559 | Schizophrenia | olanzapine | 6.07 | 17726453 20107430 20521326 | |
MESH:D012559 | Schizophrenia | Risperidone | 6.07 | 18278980 20107430 19154706 | |
MESH:C537537 | Segawa syndrome, autosomal recessive | Homovanillic Acid | 11.33 | 8817341 | |
MESH:C537537 | Segawa syndrome, autosomal recessive | Levodopa | 11.33 | 8817341 | |
MESH:D012640 | Seizures | Clonidine | 4.49 | 10087439 | |
MESH:D012640 | Seizures | Phenobarbital | 4.49 | 3137016 16876388 11442880 4039156 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.90 | 6407741 | |
MESH:D012729 | Sex Chromosome Aberrations | Chlorpyrifos | 5.16 | 6418539 | |
MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 6.37 | 12065085 | |
MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 6.37 | 8532709 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 6.37 | 16192470 | |
MESH:D012893 | Sleep Disorders | Risperidone | 4.60 | 18278980 | |
MESH:D007319 | Sleep Initiation and Maintenance Disorders | Clonidine | 4.80 | 18280681 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 8.48 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 8.48 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Progesterone | 7.85 | 16503802 15862959 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 7.85 | 19457130 | |
MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 5.49 | 1977408 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 3.42 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 2.34 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Zidovudine | 2.34 | 17696246 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 2.71 | 15138204 | |
MESH:D013576 | Syndactyly | Methotrexate | 4.16 | 9562676 | |
MESH:D013610 | Tachycardia | Norepinephrine | 4.56 | 3261545 | |
MESH:D017180 | Tachycardia, Ventricular | olanzapine | 8.32 | 20210726 | |
MESH:D017180 | Tachycardia, Ventricular | Risperidone | 8.32 | 20210726 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.76 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.36 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.97 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 4.76 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 4.76 | 1399818 | |
MESH:D013978 | Tibial Fractures | Estradiol | 3.75 | 19048282 | |
MESH:D016171 | Torsades de Pointes | Dobutamine | 4.44 | 19353679 | |
MESH:D005879 | Tourette Syndrome | Risperidone | 5.04 | 19154706 | |
MESH:D018088 | Tuberculosis, Multidrug-Resistant | entacapone | 11.62 | 19578428 | |
MESH:D018088 | Tuberculosis, Multidrug-Resistant | tolcapone | 11.62 | 19578428 | |
MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 5.80 | 11251952 | |
MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 5.80 | 16720314 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 5.80 | 17572228 16712894 8653321 | |
MESH:D014570 | Urologic Diseases | Diazinon | 4.35 | 16487989 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.14 | 10982225 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.43 | 14692618 | |
MESH:D014605 | Uveitis | Dexamethasone | 3.89 | 1336536 | |
MESH:D014625 | Vaginal Neoplasms | Zidovudine | 3.87 | 12579204 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.66 | 12125929 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.70 | 14671159 15869587 | |
MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 4.23 | 18097624 | |
MESH:D020257 | Ventricular Remodeling | Isoproterenol | 4.77 | 18097624 | |
MESH:D014820 | Vitiligo | tolcapone | 4.32 | 10573327 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.32 | 15886252 | |
MESH:D015430 | Weight Gain | Clozapine | 16.73 | 20521320 20107430 17502770 16141801 16402076 20564506 | |
MESH:D015430 | Weight Gain | Dietary Fats | 16.73 | 16723640 | |
MESH:D015430 | Weight Gain | olanzapine | 16.73 | 20107430 19434072 17933447 | |
MESH:D015430 | Weight Gain | Risperidone | 16.73 | 16379507 20564506 | |
MESH:D015431 | Weight Loss | Clozapine | 4.16 | 17933447 | |
MESH:D014947 | Wounds and Injuries | Estrogens | 3.97 | 11172683 |
Pathway ID | Pathway Name |
---|---|
REACT:13433 | Biological oxidations |
KEGG:01100 | Metabolic pathways |
KEGG:00140 | Steroid hormone biosynthesis |
REACT:13685 | Synaptic Transmission |
KEGG:00350 | Tyrosine metabolism |
Releated gene ID | Related gene Name |
---|---|
PA117 | COMT |
Releated disease ID | Related disease Name |
---|---|
PA446411 | Endometrial Neoplasms |
PA447215 | Psychotic Disorders |
PA446878 | Cocaine-Related Disorders |
PA447197 | Attention Deficit Disorder with Hyperactivity |
PA447321 | Depressive Disorder, Major |
PA445398 | Pre-Eclampsia |
PA447216 | Schizophrenia |
PA447211 | Obsessive-Compulsive Disorder |
PA447212 | Panic Disorder |
PA447199 | Bipolar Disorder |
PA447196 | Anxiety Disorders |
PA445208 | Pain |
PA445093 | Nervous System Diseases |
PA447207 | Depressive Disorder |
PA443560 | Breast Neoplasms |
PA445042 | Narcolepsy |
PA446892 | Hyperhomocysteinemia |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
PA445876 | Tobacco Use Disorder |
PA443355 | Anemia, Sickle Cell |
PA447209 | Mood Disorders |
PA445819 | Temporomandibular Joint Disorders |
PA443450 | Asthma |
PA445062 | Neoplasms |
PA445254 | Parkinson Disease |
PA446876 | Substance-Related Disorders |
PA443937 | Drug Toxicity |
PA162263534 | Ototoxicity |
PA443959 | Dyskinesia, Drug-Induced |
PA443970 | Dystonia |
PA446736 | Hypokinesia |
PA444993 | Muscle Rigidity |
PA445917 | Tremor |
Releated drug ID | Related drug Name |
---|---|
PA164754789 | conjugated estrogens |
PA449509 | estrogens |
PA164712445 | Antihypertensives |
PA451145 | propranolol |
PA452229 | antidepressants |
PA449015 | citalopram |
PA449673 | fluoxetine |
PA449396 | dopamine |
PA449088 | codeine |
PA449072 | cocaine |
PA451720 | tolcapone |
PA10066 | duloxetine |
PA448049 | adenosine |
PA450423 | l-methionine |
PA448687 | bupropion |
PA452233 | antipsychotics |
PA450688 | olanzapine |
PA452619 | heroin |
PA451257 | risperidone |
PA450550 | morphine |
PA452610 | sparteine |
PA450530 | modafinil |
PA451892 | cyanocobalamin |
PA449692 | folic acid |
PA131887008 | 3,4-methylenedioxymethamphetamine |
PA450213 | levodopa |
PA449470 | epinephrine |
PA450379 | mercaptopurine |
PA448497 | aspirin |
PA450453 | l-methyldopa |
PA452604 | xenobiotics |
PA450626 | nicotine |
PA449396 | dopamine |
PA449014 | cisplatin |
PA450464 | methylphenidate |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00323 | inhibitor | Tolcapone | Central Nervous System Agents;Antiparkinson Agents;Antidyskinetics;Enzyme Inhibitors |
DB00494 | inhibitor | Entacapone | Central Nervous System Agents;Antiparkinson Agents;Antidyskinetics;Enzyme Inhibitors |
DB02105 | - | 3,5-Dinitrocatechol | |
DB03336 | - | BIA | |
DB03907 | - | N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide | |
DB07462 | - | (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE | |
DB08049 | - | 7,8-dihydroxy-4-phenyl-2H-chromen-2-one |
Drugbank ID | Action | Drug Name | Description |
---|---|---|---|
DB00118 | - | S-Adenosylmethionine | Dietary supplement;Micronutrient |
DB00158 | - | Folic Acid | Dietary supplement;Micronutrient;Vitamin B Complex;Hematinics |
DB00161 | - | L-Valine | Dietary supplements;Essential Amino Acids;Micronutrients |
DB00255 | - | Diethylstilbestrol | Antineoplastic Agents, Hormonal;Carcinogens;Estrogens, Non-Steroidal |
DB00286 | substrate | Prempro | Estrogens |
DB00295 | - | Paregorique | Narcotics;Analgesics;Opiate Agonists;Analgesics, Opioid |
DB00494 | inhibitor | Entacapone | Central Nervous System Agents;Antiparkinson Agents;Antidyskinetics;Enzyme Inhibitors |
DB00745 | - | Modafinil | Central Nervous System Stimulants;Central Nervous System Agents;Anorexigenic Agents;Stimulants;Neuroprotective Agents |
DB00841 | - | Dobutamine | Sympathomimetics;Adrenergic beta-Agonists;Cardiotonic Agents;Sympathomimetic |
DB00968 | - | Supres 250 Tab | Antihypertensive Agents;Sympatholytics;Adrenergic alpha-Agonists |
DB00988 | - | Dopamine | Dopamine Agents;Sympathomimetics;Cardiotonic Agents;Sympathomimetic |
DB01141 | substrate | Micafungin | Antifungals;Antifungal Agents |
No data |
No data |